 Recent advancements in viral vector engineering, delivery, safety, and immunotherapy have positioned viral vector-based gene therapy at the forefront of modern medicine for treating various diseases such as metabolic, cardiovascular, muscular, hematologic, ophthalmologic, infectious, and cancer. This article was authored by Kenneth Lundstrom.